ASLAN Pharmaceuticals Limited - American Depositary Shares (ASLN)

ASLAN Pharmaceuticals shares are trading lower by 40.6% during Wednesday's session. The company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.

Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning!

ASLN stock results show that ASLAN Pharma beat analyst estimates for earnings per share the first quarter of 2024.

ASLN stock results show that ASLAN Pharma missed analyst estimates for earnings per share the fourth quarter of 2023.

BIO, the global lobbying organization for biotechnology firms, forced WuXi AppTec to leave the group due to pressure from the US Congress. Also, Boehringer Ingelheim acquired an option to license drug candidates that treat symptoms of schizophrenia.